This compound is primarily utilized in the development of pharmaceutical agents, particularly as a key intermediate in the synthesis of drugs targeting neurological and psychiatric disorders. Its structural features make it suitable for interacting with specific receptors in the brain, such as serotonin or dopamine receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, it may be explored for its potential in designing novel therapeutics for neurodegenerative diseases due to its ability to modulate neurotransmitter activity. Research also investigates its role in enhancing the efficacy and selectivity of drug candidates, contributing to advancements in precision medicine.